Economy

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Experiences Lighter than Average Trading Volume

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Experiences Lighter than Average Trading Volume”

For the next fiscal year, analysts anticipate that the company will post sales of $25.36 million per share, with estimates ranging from $16.75 million to $34.66 million. The Illinois-based Blair William Comm Il has invested 0.02% in Valero Energy Corporation (NYSE:VLO). The 50 day moving average was up $0.12 or +2.44% whereas the 200 day moving average was down $-1.13 or -18.40%. Therefore 55% are positive. IntriCon had 3 analyst reports since September 22, 2015 according to SRatingsIntel. The company was maintained on Friday, August 19 by Credit Suisse. The other 12 are split, though not evenly, between analysts who think you should buy its stock versus those who think you should sell it. Morgan Stanley maintained the stock with "Buy" rating in Monday, June 26 report. BidaskClub upgraded BioCryst Pharmaceuticals from a "strong sell" rating to a "sell" rating in a research note on Tuesday, August 1st. JP Morgan downgraded the shares of BCRX in report on Tuesday, February 9 to "Neutral" rating. As per Friday, August 12, the company rating was upgraded by Piperjaffray. As per Thursday, May 19, the company rating was initiated by UBS. (NASDAQ:BCRX) earned "Outperform" rating by FBR Capital on Tuesday, February 9. $58.48 million worth of Portola Pharmaceuticals Inc (NASDAQ:PTLA) shares were sold by Maxwell (Mauritius) Pte Ltd. 119,442 shares valued at $3.80 million were bought by BIRD JEFFREY W on Wednesday, May 31. Its up 8.21% from 25.74M shares previously. The firm has "Sell" rating by Wedbush given on Wednesday, July 12. It also upped Ishares Russell 1000 Value Etf (IWD) stake by 275,555 shares and now owns 438,321 shares. Another trade for 3,250 shares valued at $29,445 was made by STAAB THOMAS R II on Friday, March 10. Devon Energy Corp (NYSE:DVN) was raised too.

Yet another important factor while evaluating a good buy/sell decision for BioCryst Pharmaceuticals, Inc. Swiss Bank holds 0% in BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc. was covered by a number of analysts recently, 1 rated the stock as Buy, 4 rated Outperform, 3 rated Hold, 1 gave an Underperform and 0 rated sell. There are brokerage firms with lower targets than the average, including one setting a price target of $3. Therefore 73% are positive. Finally, HC Wainwright reaffirmed a "buy" rating on shares of BioCryst Pharmaceuticals in a research note on Tuesday, August 8th. Sap Ag had 40 analyst reports since July 23, 2015 according to SRatingsIntel. The firm has "Hold" rating given on Friday, August 5 by Jefferies. (NASDAQ:BCRX) has risen 75.08% since September 6, 2016 and is uptrending. JMP Securities upgraded the stock to "Market Outperform" rating in Friday, December 16 report. On Friday, July 14 the stock rating was maintained by Stifel Nicolaus with "Sell". (NASDAQ:BCRX) stock volatility was recorded 7.93% which for the previous full month was noted 6.97%.

Portola Pharmaceuticals, Inc.is a biopharmaceutical company. Vanguard Group has invested 0% of its portfolio in BioCryst Pharmaceuticals, Inc. Blackrock Institutional Tru Na holds 0% of its portfolio in IntriCon Corporation (NASDAQ:IIN) for 10,044 shares. Wells Fargo Mn reported 1 shares or 0% of all its holdings. The value of the position overall is down by 32.8%. Moreover, Susquehanna Intl Grp Limited Liability Partnership has 0% invested in BioCryst Pharmaceuticals, Inc. Bancorporation Of America Corp De reported 1,172 shares. (NASDAQ:BCRX) for 38,500 shares.

Investors sentiment increased to 1.07 in Q4 2016. Its up 0.18, from 1.5 in 2016Q3. 2,135 shares were sold by CRANZ TAWNI, worth $312,756. Barclays Plc has 0% invested in BioCryst Pharmaceuticals, Inc. Goelzer Invest Management Inc holds 121,926 shares. Meeder Asset Mgmt accumulated 0% or 1,568 shares. Bank of America downgraded BioCryst Pharmaceuticals, Inc. Instead, they should also do their own research-such as reading the prospectus for new companies or for public companies, the quarterly and annual reports filed with the SEC-to confirm whether a particular investment is appropriate for them in light of their individual financial circumstances. (BCRX) now has a value of $4.93 while the company's 52 week low is at $3.75, the shares dropped to the 52 week low on 11/04/16. Zurcher Kantonalbank (Zurich Cantonalbank) has 0% invested in BioCryst Pharmaceuticals, Inc.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.



Like this

Latest


07 September 2017
Trump Nominates Okla. Rep. For NASA Chief
In that same interview , however, Bridenstine said he is "not opposed" to studying climate change. Associate Administrator Robert Lightfoot Jr. has been serving as acting administrator.

07 September 2017
Jose and Katia become hurricanes
Additional strengthening is forecast, and Jose could be near major hurricane (wind speed greater than 110 mph) strength on Friday. Jose is moving west-northwest at about 13 miles per hour and is expected to speed up in the next two days.

07 September 2017
PSG chief says nothing to hide over massive transfers
Matic would have been £60m or £70m. "For me it was the project that was going to allow me to develop, to learn while winning". He added: "But this is a case to the contrary we want the club to respect their obligations towards the player".

07 September 2017
Hot Stock to Watch: Automatic Data Processing, Inc. (ADP)
Putnam Invests Lc stated it has 215,741 shares or 0.05% of all its holdings. 116 funds opened positions while 293 raised stakes. On average, equities research analysts predict that Automatic Data Processing will post $3.81 EPS for the current year.

07 September 2017
UnitedHealth Group Incorporated (UNH) Position Trimmed by Glenview Trust Co
It increased, as 35 investors sold CMS shares while 157 reduced holdings. 50 funds opened positions while 146 raised stakes. Karp Capital Management Corp acquired a new stake in UnitedHealth Group in the 1st quarter valued at about $113,729,000.

07 September 2017
Juvenile in stolen vehicle hits Colorado Springs police auto twice
The teenager was found taking a nap in the auto at the Crosslands Hotel off of Highway 24 on Wednesday morning. It's not yet known what charges the 15-year-old boy will face for his early morning joyride.

07 September 2017
Two men swept into sea at Treyarnon Bay
A 21-year-old fisherman has died and another is still missing after being swept off rocks into the sea in north Cornwall. A major search operation is underway after two fishermen were swept from rocks into the sea off the Cornish coast.

07 September 2017
Wenger promises £60-70m signing to replace Sanchez
Speaking to BeIN Sports , Arsene Wenger says Arsenal have sacrificed to 60 to 70 million pounds by not selling Alexis this past summer.

07 September 2017
Brokerages Set Koninklijke Philips NV (PHG) PT at $33.50
The stock of Koninklijke Philips NV (ADR) (NYSE:PHG) has "Buy" rating given on Wednesday, November 23 by Citigroup. BNP Paribas upgraded Koninklijke Philips NV (ADR) (NYSE:PHG) on Wednesday, May 11 to "Outperform" rating.

07 September 2017
The Palladium Partners LLC Sells 1747 Shares of Stryker Corporation (SYK)
For SYK, the company now has $3.65 Billion of cash on the books, which is offset by $774 Million current liabilities. Hyslop Gregory L sold $922,738 worth of stock. $1.47M worth of stock was sold by LUTTIG J MICHAEL on Tuesday, May 2.



Recommended